108 related articles for article (PubMed ID: 21703983)
1. Diagnostic microRNAs in myelodysplastic syndrome.
Erdogan B; Facey C; Qualtieri J; Tedesco J; Rinker E; Isett RB; Tobias J; Baldwin DA; Thompson JE; Carroll M; Kim AS
Exp Hematol; 2011 Sep; 39(9):915-926.e2. PubMed ID: 21703983
[TBL] [Abstract][Full Text] [Related]
2. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O
Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598
[TBL] [Abstract][Full Text] [Related]
3. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow.
Gao J; Yang T; Han J; Yan K; Qiu X; Zhou Y; Fan Q; Ma B
J Cell Biochem; 2011 Jul; 112(7):1844-56. PubMed ID: 21416501
[TBL] [Abstract][Full Text] [Related]
5. Microarray analysis of differentially expressed microRNAs in allergic rhinitis.
Shaoqing Y; Ruxin Z; Guojun L; Zhiqiang Y; Hua H; Shudong Y; Jie Z
Am J Rhinol Allergy; 2011; 25(6):e242-6. PubMed ID: 22185732
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations.
Aslan D; Garde C; Nygaard MK; Helbo AS; Dimopoulos K; Hansen JW; Severinsen MT; Treppendahl MB; Sjø LD; Grønbæk K; Kristensen LS
Oncotarget; 2016 Mar; 7(9):9951-63. PubMed ID: 26848861
[TBL] [Abstract][Full Text] [Related]
7. Deregulation of microRNAs in myelodysplastic syndrome.
Rhyasen GW; Starczynowski DT
Leukemia; 2012 Jan; 26(1):13-22. PubMed ID: 21852786
[TBL] [Abstract][Full Text] [Related]
8. SLC7A5 act as a potential leukemic transformation target gene in myelodysplastic syndrome.
Ma Y; Song J; Chen B; Xu X; Lin G
Oncotarget; 2016 Feb; 7(6):6566-75. PubMed ID: 26657287
[TBL] [Abstract][Full Text] [Related]
9. The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma.
Zhi F; Chen X; Wang S; Xia X; Shi Y; Guan W; Shao N; Qu H; Yang C; Zhang Y; Wang Q; Wang R; Zen K; Zhang CY; Zhang J; Yang Y
Eur J Cancer; 2010 Jun; 46(9):1640-9. PubMed ID: 20219352
[TBL] [Abstract][Full Text] [Related]
10. Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma.
Sand M; Skrygan M; Georgas D; Sand D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
J Dermatol Sci; 2012 Dec; 68(3):119-26. PubMed ID: 23026055
[TBL] [Abstract][Full Text] [Related]
11. Analysis of microRNA expression profiling identifies miR-155 and miR-155* as potential diagnostic markers for active tuberculosis: a preliminary study.
Wu J; Lu C; Diao N; Zhang S; Wang S; Wang F; Gao Y; Chen J; Shao L; Lu J; Zhang X; Weng X; Wang H; Zhang W; Huang Y
Hum Immunol; 2012 Jan; 73(1):31-7. PubMed ID: 22037148
[TBL] [Abstract][Full Text] [Related]
12. Expression of microRNAs in basal cell carcinoma.
Sand M; Skrygan M; Sand D; Georgas D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
Br J Dermatol; 2012 Oct; 167(4):847-55. PubMed ID: 22540308
[TBL] [Abstract][Full Text] [Related]
13. Microarray analysis of differentially expressed microRNAs in myelodysplastic syndromes.
Wan C; Wen J; Huang Y; Li H; Wu W; Xie Q; Liang X; Tang Z; Zhao W; Cheng P; Liu Z
Medicine (Baltimore); 2020 Jul; 99(27):e20904. PubMed ID: 32629683
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-194-5p could serve as a diagnostic and prognostic biomarker in myelodysplastic syndromes.
Choi JS; Nam MH; Yoon SY; Kang SH
Leuk Res; 2015 Jul; 39(7):763-8. PubMed ID: 25975751
[TBL] [Abstract][Full Text] [Related]
15. [Transcriptome profiling of marrow mononuclear cells of patients with myelodysplastic syndrome using cDNA microarray analysis].
Qian J; Chen ZX; Wang W; Cen JN; Xue YQ
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1260-4. PubMed ID: 15387962
[TBL] [Abstract][Full Text] [Related]
16. Aberrant microRNA expression pattern in myelodysplastic bone marrow cells.
Hussein K; Theophile K; Büsche G; Schlegelberger B; Göhring G; Kreipe H; Bock O
Leuk Res; 2010 Sep; 34(9):1169-74. PubMed ID: 20627384
[TBL] [Abstract][Full Text] [Related]
17. Identification of differentially expressed microRNAs by microarray: a possible role for microRNAs gene in medulloblastomas.
Liu W; Gong YH; Chao TF; Peng XZ; Yuan JG; Ma ZY; Jia G; Zhao JZ
Chin Med J (Engl); 2009 Oct; 122(20):2405-11. PubMed ID: 20079150
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma.
Won KY; Kim YW; Kim HS; Lee SK; Jung WW; Park YK
Hum Pathol; 2013 Aug; 44(8):1648-55. PubMed ID: 23574781
[TBL] [Abstract][Full Text] [Related]
19. Identification of defects in the transcriptional program during lineage-specific in vitro differentiation of CD34(+) cells selected from patients with both low- and high-risk myelodysplastic syndrome.
Gueller S; Komor M; Nowak D; Baldus CD; de Vos S; Hoelzer D; Ottmann OG; Hofmann WK
Exp Hematol; 2010 Sep; 38(9):718-32, 732.e1-6. PubMed ID: 20621626
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
